[Federal Register Volume 63, Number 67 (Wednesday, April 8, 1998)]
[Notices]
[Page 17192]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-9226]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute meetings:

    Name of Committee: Clinical Trials Review Committee.
    Date: June 21-23, 1998.
    Time: 7:00 p.m.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, Maryland 20814.
    Contact Person: Joyce A. Hunter, Ph.D., Two Rockledge Center, 
Room 7192, 7601 Rockledge Drive, Bethesda, Maryland 20982-7924, 
(301) 435-0287.
    Purpose/Agenda: To review and evaluate Clinical Trial and R03 
grant applications.

    Name of Committee: National Heart, Lung, and Blood Special 
Emphasis Panel (A Related Umbilical Cord Blood Bank for 
Hemoglobinopathy Patients)--Telephone Conference Call.
    Date: May 11, 1998.
    Time: 2:00 p.m.
    Place: Rockledge Center II, Room 7214, 6701 Rockledge Drive, 
Bethesda, Maryland 20892-7924.
    Contact Person: Camille King, Ph.D., Two Rockledge Center, Room 
7208A, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0321.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of Committee: National Heart, Lung, and Blood Special 
Emphasis Panel (Immunogenetics of Inhibitor Formation in Hemophilia.
    Date: June 15, 1998.
    Time: 8:00 a.m.
    Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver 
Spring, Maryland 20910.
    Contact Person: Deborah Beebe, Ph.D., Two Rockledge Center, Room 
7178, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0270.
    Purpose/Agenda: To review and evaluate grant applications.

    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: April 2, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-9226 Filed 4-7-98; 8:45 am]
BILLING CODE 4140-01-M